Gino Santini
Gino Santini is on the board of ImClone LLC and 7 other companies. Mr. Santini previously occupied the position of Senior VP-Business Development & Strategy at Eli Lilly & Co. and General Manager for Eli Lilly y CIA de México SA de CV (a subsidiary of Eli Lilly & Co.), Chairman for AMAG Pharmaceuticals, Inc., Chairman at National Pharmaceutical Council and Chairman at Noble of Indiana.
He received an undergraduate degree from Alma Mater Studiorum - Università di Bologna and an MBA from the University of Rochester Simon Business School.
Transactions
Date
Transaction
Value
| 04/29/2022 | 1,658 | Derivative/Non-derivative trans. at $98.56 per share. | 163,413 |
| 04/29/2022 | 4,223 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 04/30/2021 | 4,357 | Derivative/Non-derivative trans. at $94.62 per share. | 412,260 |
| 04/30/2021 | 11,098 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 03/01/2021 | 12,000 | Disposition at $91.47 per share. | 1,097,640 |
| 08/03/2020 | 20,000 | Derivative/Non-derivative trans. at $2.37 per share. | 47,400 |
| 08/03/2020 | 5,265 | Derivative/Non-derivative trans. at $3.95 per share. | 20,796 |
| 08/03/2020 | 10,530 | Derivative/Non-derivative trans. at $3.33 per share. | 35,064 |
| 05/02/2020 | 6,041 | Derivative/Non-derivative trans. at $35.62 per share. | 215,181 |
| 05/02/2020 | 15,390 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 05/03/2019 | 6,014 | Derivative/Non-derivative trans. at $26.54 per share. | 159,612 |
| 05/03/2019 | 15,320 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 05/03/2018 | 5,517 | Derivative/Non-derivative trans. at $13.87 per share. | 76,521 |
| 05/03/2018 | 14,054 | Derivative/Non-derivative trans. at $0 per share. | 0 |
